US beauty group faces investor pressure as sales contract, cost cuts deepen, and fragrance licenses emerge as both growth engine and looming risk. Image: Gucci perfume/Weibo
US beauty group faces investor pressure as sales contract, cost cuts deepen, and fragrance licenses emerge as both growth engine and looming risk. Image: Gucci perfume/Weibo
Contents
- What happened: Shareholder scrutiny deepens after earnings miss
- First full-year revenue decline in four years
- The Jing Take: Cost cuts, US production shift, and China leadership shakeup
- Divestment speculation grows as luxury groups in-source beauty
- Reliance on fragrance licenses poses both strength and risk
- Recommended
- Dig Deeper